Gavi’s impact in 2024 in seven key statistics
In the time it takes you to read this article, six people’s lives will have been saved by Gavi-supported vaccines. Here are seven statistics on Gavi’s impact in 2024.
- 30 September 2025
- 5 min read
- by Gavi Staff
The challenges the world is dealing with continue to be exacerbated year on year – greater fragility, geopolitical and economic uncertainty and climate change are all compounding to drive increased infectious disease outbreaks. The data from 2024 is clear: vaccines are more important than ever.
This brings the total number of children immunised with help from Gavi since 2000 to 1.2 billion. This is more than one-seventh of the total global population, protected by the Vaccine Alliance.
Across the year, Gavi kept its focus on routine immunisation while responding to more health emergencies than ever, as well as catching up on vaccinations that were disrupted during the COVID-19 pandemic.
Gavi’s 2024 Annual Progress Report charts recent progress and highlights the scale of the challenges ahead. Here are seven key statistics outlined in the report.
1. Over 20.6 million lives saved since 2000
In the time it takes you to read this article, six people’s lives will have been saved by Gavi-supported vaccines.
A staggering 1.7 million future deaths will be prevented by Gavi-supported vaccines administered in 2024 alone – the most lives saved in a single year since Gavi’s inception. And Gavi’s vaccine deliveries since its inception have helped to halve child mortality in 78 lower-income countries.
Gavi-supported countries continue to have higher coverage rates for vaccines against pneumococcus, rotavirus and Haemophilus influenzae type b (Hib) than the rest of the world.
2. Gavi-supported countries have immunised more than 1.2 billion children since 2000
In 2024 alone, Gavi-supported countries protected more than 72 million children against a range of infectious diseases, more than any previous year on record. This brings the total number of children immunised with help from Gavi since 2000 to 1.2 billion. This is more than one-seventh of the total global population, protected by the Vaccine Alliance.
This means that in total over 2.1 billion vaccinations have been delivered through preventive vaccination campaigns from 2000 to 2024, protecting the most vulnerable children in the world from diseases like measles, rubella, polio and pneumonia.
That period of 2000–2024 saw 695 vaccine introductions and preventive vaccination campaigns (excluding COVAX) – in addition to 50 outbreak response vaccination campaigns supported by Gavi in 2024 alone.
3. More than 32.6 million girls protected with HPV vaccine in 2024 – more than the previous ten years combined
In 2024 alone, 32.6 million girls were fully immunised with HPV vaccine with Gavi support – this was more than the previous ten years of Gavi-supported HPV vaccination combined.
As a result of Gavi’s investment, more than 1.2 million future cervical cancer deaths have been averted by Gavi-supported HPV vaccinations from 2014–2024. In 2024 alone, over 616,000 future cervical cancer deaths have been averted by Gavi-supported HPV vaccination – more than double the previous year.
Have you read?
In 2024, coverage of the last dose in the schedule of HPV vaccine increased by 9 percentage points among the 57 lower-income countries supported by Gavi to 25%, nearing parity with the global average of 28%.
4. World’s first malaria vaccines rolled out in 17 endemic countries in Africa in 2024 with Gavi support
2024 saw a historic moment in global health: the world’s first malaria vaccines were introduced into routine immunisation programmes, protecting millions – most of them children aged under five years – from a killer disease.
This was a significant breakthrough in the 30-year search for a malaria vaccine. The 2024 malaria vaccine roll-out was the fastest in the Alliance’s 25-year history, and today the vaccine is protecting children across 23 endemic African countries.
By the end of 2024, more than 10.5 million malaria vaccine doses had been procured and delivered to 17 endemic countries with Gavi support.
For families in these communities, the malaria vaccine adds a powerful new layer of protection alongside mosquito nets and seasonal malaria chemoprevention. Together, these interventions are expected to save tens of thousands of young lives every year.
5. The number of unimmunised children fell by half a million since 2023
One of Gavi’s core goals is to reduce the number of ‘zero-dose’ children – those who haven’t received a single DTP vaccination by their first birthday – as they are extremely vulnerable to disease and are also most likely to live in communities with little access to healthcare.
In 2024, there were 10.2 million zero-dose children, a decrease of half a million zero-dose children from 2023. This represents a 5% decrease from 2023 and a 17% decrease from 2021. However, reaching Gavi’s target by the end of 2025 will require a 32% reduction from 2024.
6. US$ 280 billion in economic benefits since 2000
In 2024 alone, over US$ 19.8 billion in economic benefits were generated by helping to create healthier populations, leading to reduced healthcare costs and more productive communities.
A study of 73 Gavi-supported countries showed that, for every US$ 1 spent on immunisation in the 2021–2030 period, US$ 21 are saved in healthcare costs, lost wages and lost productivity due to illness and death.
When the broader societal impact is taken into account, the return on investment is estimated to be US$ 54 per US$ 1 spent.
7. Co-financing of Gavi-supported vaccines surpassed US$ 250 million for the first time
2024 was another record-breaking year for countries contributing to the cost of their immunisation programmes.
In 2024, country co-financing of Gavi-supported vaccines crossed the US$ 250 million mark for the first time, reaching US$ 255 million. Since 2008, Gavi countries have co-financed a total of US$ 1.9 billion.
55 vaccine programmes originally introduced with Gavi funding are self-financed by countries as of 2023, up from 40 in 2018.
More from Gavi Staff
